ResMed Partners with NASCAR Driver Tyler Reddick to Raise Sleep Apnea Awareness
Event summary
- ResMed collaborates with NASCAR driver Tyler Reddick to promote sleep apnea awareness.
- Reddick, diagnosed with obstructive sleep apnea (OSA) in early 2026, credits CPAP therapy for improved performance.
- ResMed branding will appear on Reddick’s No. 45 Toyota Camry XSE at three NASCAR races in 2026.
- OSA affects nearly 1 billion people globally, with over 80% of cases undiagnosed.
The big picture
ResMed’s partnership with Tyler Reddick leverages sports performance to highlight the critical role of sleep health. This collaboration aligns with broader industry trends where health tech companies are increasingly partnering with high-profile athletes to promote wellness. The initiative targets the significant gap in OSA diagnosis, potentially expanding ResMed’s market reach in both consumer and medical sectors.
What we're watching
- Awareness Impact
- Whether Reddick’s public diagnosis will accelerate OSA awareness and diagnosis rates.
- Performance Metrics
- How CPAP therapy adoption among athletes could influence broader public health trends.
- Brand Visibility
- The effectiveness of ResMed’s NASCAR sponsorship in boosting brand recognition.
Related topics